For the latest
cancer COVID-19 resources, click on this link
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Brain & nervous system
Sign up for latest coverage
Submit your event
cancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Prevention & screening
Middle East and North Africa
Central America and the Caribbean
Australia and Oceania
1 - 4 Dec 2018
San Diego Convention Center, San Diego, United States of America
ASH 2018: Cancer patients show reduced risk of harmful clots while taking direct oral anticoagulants
ASH 2018: Ibrutinib-based therapy more effective, safer in younger patients with previously untreate...
ASH 2018: Researchers identify mutation in BCL2 protein that causes resistance to venetoclax
ASH 2018: Daratumumab increases progression-free survival in transplant-ineligible multiple myeloma
ASH 2018: More than half of patients alive two years after receiving CAR-T therapy for diffuse large...
ASH 2018: Machine learning-based model improves prognosis accuracy for myelodysplastic syndromes
ASH 2018: Rapid genetic screening shows feasibility of precision medicine for acute myeloid leukaemi...
ASH 2018: Disruptions in the gut microbiota before hematopoietic cell transplantation associated wit...
ASH 2018: A first stem cell transplant after CAR T-Cell therapy reduces relapses in ALL
ASH 2018: Inhibiting the immune system’s natural response may boost benefits and sustainability of C...
ASH 2018: Concurrent ibrutinib may improve outcomes, reduce toxicity of CAR T-Cell Therapy with JCAR...
ASH 2018: Longer term data validate durable responses with tisagenlecleucel in adults with relapsed ...
ASH 2018: Tisagenlecleucel continues to show durable remissions in kids and young adults with stubbo...
ASH 2018: CAR T-Cell therapies show durable responses, new research also explores combination therap...
ASH 2018: Two studies suggest luspatercept reduces need for blood transfusions
ASH 2018: Four cycles of chemotherapy as effective as six for diffuse large B-Cell lymphoma
ASH 2018: Ibrutinib outperforms chemoimmunotherapy in older patients with chronic lymphocytic leukae...
ASH 2018: Alvocidib shows encouraging activity in patients with MCL-1 dependent relapsed or refracto...